Comparative Outcome Study between Resolved and Unresolved St Segment in St Segment Elevation Acutemyocardial Infarction (STEMI) after Thrombolytic Therapy

نویسندگان

چکیده

Background: To study the comparative outcome between resolved an unresolved ST segment in Segment Elevation Acute Myocardial Infarction (STEMI), after thrombolytic therapy. Method: A was carried out on patients admitted with 1st episode of elevated myocardial infarction MICU a tertiary health care center teaching hospital. On admission detailed history taken and complete clinical examination done. Thrombolysis done using streptokinase, 2D ECHOs were performed before Result: Most population both group (Unresolved STEMI Successful thrombolysis), belonged to age 41 50 years. Co-morbidities like hypertension present 83% Unresolved 53% Resolved STEMI. Comorbidities diabetes 66.7% 52.6% RWMA 2D-Echo thrombolysis 58.3% 47.4% 18.5% Conclusion: Symptom needle time is important predictor whether will be successful or not acute patients. Hence it educate public about prompt recognition symptoms seeking medical help urgently. As rate unsuccessful higher old age, diabetes, dyslipidemia, such should monitored treated aggressively.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Prehospital thrombolytic therapy for ST-segment elevation myocardial infarction.

The results of the ER-TIMI (Thrombolysis in Myocardial Infarction) 19 trial (1) provide yet another building block in the case for prehospital administration of thrombolytic agents to patients presenting with acute ST-segment elevation myocardial infarction (MI). These results reflect as accurately as possible the contemporary impact on time to administration (32-min decrease), and they come at...

متن کامل

reviewing time intervals from onset of the symptoms to thrombolytic therapy in patients with st segment elevation myocardial infarction (stemi)

background : coronary artery diseases are one of the causes of early death all over the world. in developed countries, ischemic heart disease is responsible for the half of the entire mortalities; however in developing countries it is estimated from 9 million deaths per year annually 32 percent of all deaths due to coronary artery disease. acute coronary syndromes are responsible for over 250,0...

متن کامل

Study of the Duration, Outcomes, and Related Factors of Reperfusion Therapy in Patients with ST-Segment Elevation Myocardial Infarction

Background and Objective: One of the most important advancements regarding the care of patients with acute myocardial infarction is the administration of anti-coagulation medicines (e.g., streptokinase). However, it must be noticed that this medicine requires rapid and timely administration. Moreover, Percutaneous Coronary Intervention (PCI) is increasingly used as a method of revascularization...

متن کامل

Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI)

The use of fibrinolytic agents in the early treatment of ST-segment elevation myocardial infarction (STEMI) is known to significantly reduce mortality. Accelerated (“frontloaded”) alteplase is being challenged as the standard of care for pharmacological reperfusion. Alteplase, reteplase, and streptokinase have several limitations. The search for newer agents has focused on developing a fibrinol...

متن کامل

Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.

BACKGROUND Clinical guidelines recommend similar medical therapy for patients with ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation MI (NSTEMI). METHODS AND RESULTS Using the Get with the Guidelines-Coronary Artery Disease registry (GWTG-CAD), we analyzed data including 72 352 patients (48 966, NSTEMI; 23 386, STEMI) from 237 US sites between May 1, 2006 and Mar...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: MVP journal of medical science

سال: 2023

ISSN: ['2348-263X', '2348-2648']

DOI: https://doi.org/10.18311/mvpjms/2022/v9i1/294